As it continues a proxy fight with activist investor Macellum Advisors, Kohl’s Corp. has issued a letter to shareholders on behalf of incoming chair Peter Boneparth in connection with the company’s May 11 annual meeting and its board of directors election. Bonaparth...
As part of its ongoing struggle with an activist investor, Kohl’s Corp. has sent a letter to shareholders asking for their votes to return its current board of directors and reject that proposed by Macellum Advisors. The letter detailed steps taken by the board of...
In its ongoing fight with activist investor Macellum Advisors, Kohl’s Corp. has issued a statement saying it has engaged with firms interested in purchasing the company, but, in a separate letter, that it would oppose any replacement of its board in a proxy fight....
Kohl’s Corp. has rejected the advice of activist investors and buy-out offers, adopted a poison pill and squared off against the firm leading the effort to reconstitute the company, Macellum Advisors. The Kohl’s board of directors has issued a statement...
